{
    "clinical_study": {
        "@rank": "36991", 
        "arm_group": [
            {
                "arm_group_label": "Picosure Laser System", 
                "arm_group_type": "Experimental", 
                "description": "Picosure Laser System for the Treatment of Unwanted Tattoos"
            }, 
            {
                "arm_group_label": "Revlite Laser System", 
                "arm_group_type": "Experimental", 
                "description": "Revlite Laser System for the Treatment of Unwanted Tattoos"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the Picosure and Revlite Laser Systems for the\n      treatment of unwanted tattoos."
        }, 
        "brief_title": "Picosure Alexandrite Laser and Revlite Nd:Yag Laser for the Treatment of Unwanted Tattoos", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Unwanted Tattoos", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Is a healthy non-smoking (must have quit 6 months prior) male or female between 18\n             and 65 years old.\n\n          2. Is willing to consent to participate in the study.\n\n          3. Is willing to comply with all requirements of the study including being photographed,\n             following post treatment care and attending all treatment and follow up visits.\n\n        Exclusion Criteria:\n\n          1. The subject is female and pregnant, has been pregnant within the last 3 months, is\n             currently breast feeding or planning a pregnancy during the study period.\n\n          2. The subject is hypersensitive to light exposure OR takes photo sensitizing\n             medication.\n\n          3. The subject has active or localized systemic infections.\n\n          4. The subject has a coagulation disorder or is currently using anti-coagulation\n             medication (including but not limited to heavy aspirin therapy {greater than 81 mg\n             per day}).\n\n          5. The subject has any condition which, in the investigator's opinion, would make it\n             unsafe for the subject to participate in this research study.\n\n          6. The subject is currently enrolled in an investigational drug or device trial, or has\n             received an investigational drug or been treated with an investigational device\n             within 3 months prior to entering this study.\n\n          7. The subject has used Accutane within 6 months prior to enrollment.\n\n          8. The subject has the need to be exposed to artificial tanning devices or excessive\n             sunlight during the trial.\n\n          9. The subject has had prior treatment with parenteral gold therapy (gold sodium\n             thiomalate).\n\n         10. The subject has a history of keloid scar formation.\n\n         11. The subject has evidence of compromised wound healing.\n\n         12. The subject has a history of basal cell carcinoma, squamous cell carcinoma or\n             melanoma.\n\n         13. The subject has a history of immunosuppression/immune deficiency disorders (including\n             HIV infection or AIDS) or use of immunosuppressive medications or has an autoimmune\n             disorder.14. The subject has red tattoo ink allergy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02110121", 
            "org_study_id": "CYN13-PICOREVLITE"
        }, 
        "intervention": [
            {
                "arm_group_label": "Picosure Laser System", 
                "description": "Picosure Laser System for the Treatment of Unwanted Tattoos", 
                "intervention_name": "Picosure Laser System", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Revlite Laser System", 
                "description": "Revlite Laser System for the Treatment of Unwanted Tattoos", 
                "intervention_name": "Revlite Laser System", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 8, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Westford", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "01886"
                }, 
                "name": "Cynosure Inc."
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Picosure Alexandrite Laser and Revlite Nd:Yag Laser for the Treatment of Unwanted Tattoos", 
        "overall_official": {
            "affiliation": "Cynosure, Inc.", 
            "last_name": "Patricia Krantz", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Clearance will be measured using a photographic scale. Photographs will be taken of the subjects at baseline and post treatment. The results will be compared to determine clearance.", 
            "measure": "Tattoo clearance", 
            "safety_issue": "No", 
            "time_frame": "2 months post treatment last treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02110121"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Cynosure, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cynosure, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}